Verition Fund Management’s Aldeyra Therapeutics ALDX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
|
|||||
|
2025
Q1 | $216K | Buy |
|
|||||
|
2024
Q4 | – | Sell |
|
|||||
|
2024
Q3 | $181K | Sell |
|
|||||
|
2024
Q2 | $728K | Sell |
|
|||||
|
2024
Q1 | $3.08M | Sell |
|
|||||
|
2023
Q4 | $4.65M | Buy |
|
|||||
|
2023
Q3 | $6.25M | Buy |
|
|||||
|
2023
Q2 | $7.8M | Sell |
|
|||||
|
2023
Q1 | $15.5M | Buy |
|
|||||
|
2022
Q4 | $10.8M | Sell |
|
|||||
|
2022
Q3 | $12.8M | Buy |
|
|||||
|
2022
Q2 | $7.59M | Sell |
|
|||||
|
2022
Q1 | $9.36M | Buy |
|
|||||
|
2021
Q4 | $5.47M | Buy |
|
|||||
|
2021
Q3 | $5.69M | Buy |
|
|||||
|
2021
Q2 | $5.98M | Buy |
|
|||||
|
2021
Q1 | $4.95M | Buy |
|
|||||
|
2020
Q4 | $1.35M | Sell |
|
|||||
|
2020
Q3 | $2.19M | Buy |
|
|||||
|
2020
Q2 | $92K | Buy |
|
|||||
|
2019
Q2 | – | Sell |
|
|||||
|
2019
Q1 | $2.48M | Buy |
|
|||||
|
2018
Q4 | $1.25M | Buy |
|